 | |
| Clinical data | |
|---|---|
| Routes of administration | Topical |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.011.169 |
| Chemical and physical data | |
| Formula | C9H4Cl3IO |
| Molar mass | 361.38 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 113.5 °C (236.3 °F) |
| Solubility in water | Insoluble mg/mL (20 °C) |
| |
| |
| (verify) | |
Haloprogin is anantifungal drug used to treatathlete's foot and otherfungalinfections.[1] It is marketed in creams under the trade namesHalotex,Mycanden,Mycilan, andPolik.
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketedover-the-counter primarily to treattinea infections of theskin. The mechanism of action is unknown.[2]
Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[3]
 | Thisantiinfectivedrug article is astub. You can help Wikipedia byadding missing information. |
 | Thisdermatologicdrug article is astub. You can help Wikipedia byadding missing information. |
